Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality
Science Advances · 06.06.2025 · 11 (23)
DOI: 10.1126/sciadv.adt1466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 06.06.2025. Verfasst von Alexander P de Porto und 26 weiteren Autor:innen. Beteiligte Einrichtung: Duchossois Family Institute, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Critical Illness, Feces, Gastrointestinal Microbiome, Metabolome. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Critically ill patients admitted to the medical intensive care unit (MICU) have reduced intestinal microbiota diversity and altered microbiome-associated metabolite concentrations. Metabolites produced by the gut microbiota have been associated with survival of patients receiving complex medical treatments and thus might represent a treatable trait to improve clinical outcomes. We prospectively collected fecal specimens, defined microbiome compositions by shotgun metagenomic sequencing, and quantified microbiota-derived fecal metabolites by mass spectrometry from 196 critically ill patients admitted to the MICU for non–COVID-19 respiratory failure or shock to correlate microbiota features and metabolites with 30-day mortality. Microbiota compositions of the first fecal sample after MICU admission did not independently associate with 30-day mortality. We developed a metabolic dysbiosis score (MDS) that uses fecal concentrations of 13 microbiota-derived metabolites, which predicted 30-day mortality independent of known confounders. The MDS complements existing tools to identify patients at high risk of mortality by incorporating potentially modifiable, microbiome-related, independent contributors to host resilience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Duchossois Family Institute, University of Chicago, Chicago, IL 60637, USA.
- Department of Internal Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Noord Holland 1081 HV, Netherlands.
- Ecolab, Saint Paul, MN 55102, USA.
- Division of Pulmonary and Critical Care Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL 60612, USA.
- New York Institute of Technology College of Osteopathic Medicine, Glen Head, NY 11545, USA.
- Department of Biological Sciences, Northern Illinois University, DeKalb, IL 60115, USA.
ORCID-Profile: Alexander P de Porto, Huaiying Lin, Michael W Mullowney, Jessica Little, Amber Rose, David Moran, Victoria Burgo, Rita Smith, Carolyn Metcalfe, Ramanujam Ramaswamy, Christopher Lehmann, Jack Zhao, Marie Kim, Anitha Sundararajan, John P Kress, Eric G Pamer, Bhakti K Patel
Förderung
- NHLBI NIH HHS
Zitieren
APA
de Porto, A. P., Dylla, N. P., Stutz, M., Lin, H., Khalid, M., Mullowney, M. W., Little, J., Rose, A., Moran, D., McMillin, M., Burgo, V., Smith, R., Woodson, C., Metcalfe, C., Ramaswamy, R., Lehmann, C., Odenwald, M., Bandealy, N., Zhao, J., …, & Patel, B. K. (2025). Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality. Science Advances, 11(23). https://doi.org/10.1126/sciadv.adt1466
Vancouver
de Porto AP, Dylla NP, Stutz M, Lin H, Khalid M, Mullowney MW, et al. Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality. Science Advances. 2025;11(23). doi:10.1126/sciadv.adt1466
BibTeX
@article{dePorto2025,
author = {de Porto, Alexander P and Dylla, Nicholas P and Stutz, Matthew and Lin, Huaiying and Khalid, Maryam and Mullowney, Michael W and Little, Jessica and Rose, Amber and Moran, David and McMillin, Mary and Burgo, Victoria and Smith, Rita and Woodson, Che and Metcalfe, Carolyn and Ramaswamy, Ramanujam and Lehmann, Christopher and Odenwald, Matthew and Bandealy, Nadeem and Zhao, Jack and Kim, Marie and Adler, Emerald and Sundararajan, Anitha and Sidebottom, Ashley and Kress, John P and Wolfe, Krysta S and Pamer, Eric G and Patel, Bhakti K},
title = {Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {23},
doi = {10.1126/sciadv.adt1466}
}
EUVIMED